Catalyst Wire Dossier Catalyst Wire Dossier

BREKIYA

Dihydroergotamine mesylate · Amneal Pharmaceuticals LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BREKIYA, covering 2025-05-14 to 2025-05-14. Get the full timeline:

Most recent: FDA Approved: BREKIYA — Original Application (Amneal Pharmaceuticals LLC)

See pricing